ATI RN
Central Nervous System Stimulants and Related Drugs NCLEX Questions Quizlet Questions
Question 1 of 5
Which is a nursing intervention for a patient taking carbidopa-levodopa for Parkinson disease?
Correct Answer: B
Rationale: The correct answer is B: Inform the patient that perspiration may be dark and may stain clothing. This is because carbidopa-levodopa can cause dark sweat due to its effect on dopamine levels. This information is crucial for patient education to prevent unnecessary concerns or distress. Choice A is incorrect because high-protein intake can interfere with the absorption of levodopa, leading to reduced effectiveness of the medication. Choice C is incorrect because checking glucose levels with urine testing is not relevant for monitoring the effects of carbidopa-levodopa in Parkinson's disease. Blood glucose monitoring would be more appropriate for diabetes management. Choice D is incorrect because the onset of action for carbidopa-levodopa is typically faster, within hours to days, rather than 4 to 5 days. It is important for the patient to be aware of the potential side effects and expected timeline for symptom improvement.
Question 2 of 5
The nurse is teaching a patient recently diagnosed with multiple sclerosis about the disease. Which statement is not correct concerning multiple sclerosis?
Correct Answer: B
Rationale: The correct answer is B because the statement that the goals of treatment are to decrease inflammation in the nervous system is not correct for multiple sclerosis. While inflammation plays a role in the development of MS, the primary goal of treatment is to manage symptoms, slow down the progression of the disease, and improve the patient's quality of life. Treatments may include medications to reduce relapses, manage symptoms, and modify the course of the disease. Choices A, C, and D are incorrect as they accurately describe characteristics of multiple sclerosis such as periods of exacerbations and remissions, symptoms like muscle weakness, fatigue, vision and emotional problems, and the autoimmune nature of the disorder causing plaque development.
Question 3 of 5
The nurse anticipates that the health care provider will prescribe which medication to treat a patient with relapsing remitting multiple sclerosis?
Correct Answer: D
Rationale: The correct answer is D: Glatiramer acetate. This medication is commonly used to treat relapsing-remitting multiple sclerosis by reducing the frequency of relapses. It works by modulating the immune system to prevent inflammation and damage to the nervous system. Ambenonium (A) and Pyridostigmine (B) are used to treat myasthenia gravis, a neuromuscular disorder, not multiple sclerosis. Mitoxantrone (C) is used for aggressive forms of multiple sclerosis, not for relapsing-remitting MS. In summary, Glatiramer acetate is the correct choice for treating relapsing-remitting multiple sclerosis due to its mechanism of action and proven efficacy.
Question 4 of 5
The nurse is providing medication instructions to a patient with acute muscle spasms who has been prescribed cyclobenzaprine. Which statement indicates to the nurse that the patient understands the instructions?
Correct Answer: A
Rationale: Correct Answer: A Rationale: 1. Cyclobenzaprine can cause drowsiness, so it is recommended to take it at bedtime. 2. Taking it with a glass of milk can help minimize stomach upset. 3. The patient's understanding is demonstrated by planning to take it with milk for optimal effect and compliance. Summary: B: Incorrect. While cyclobenzaprine can be taken at bedtime, the patient's understanding is not demonstrated by this statement. C: Incorrect. Drinking alcohol, even in moderation, can increase drowsiness and impair cognitive function. D: Incorrect. Grapefruit juice can interact with cyclobenzaprine, leading to potentially harmful side effects.
Question 5 of 5
A patient is beginning to take cyclobenzaprine for treatment of acute back spasms. Which interventions will the nurse include in the care of this patient? (Select all that apply.)
Correct Answer: B
Rationale: The correct answer is B: Inform the patient not to abruptly stop taking the muscle relaxant. Abruptly stopping cyclobenzaprine can lead to withdrawal symptoms. Gradual tapering is necessary to prevent adverse effects. Choice A is incorrect as cyclobenzaprine can be taken with or without food. Choice C is incorrect as alcohol should be avoided while taking muscle relaxants. Choice D is irrelevant to the question and not related to the care of a patient taking cyclobenzaprine.